New York, NY 19 May 2021: Polaris Market Research assumes that with the expected launch of the potential promising therapies, the market is anticipated to expand in both psoriasis and atopic dermatitis segments. The Unites States accounts for the higher share of the market as compared to the Europe and Japan. The highest market size is due to the increased adoption of high priced biologics. Despite the launch and availability of multiple biologics, only 10% of the patients have access to these treatments and the market continues to remain underpenetrated.
Currently, the dermatology drugs market is highly fragmented but offer several commercial opportunities. There remains significant unmet need for safer and cost-effective treatment options. Psoriasis market was nearly USD 6 billion markets in 2016 due to the existing effective TNF alpha treatments. In Acne, retinoids and antibiotics are the mainstay treatments but what makes this indication lucrative is the promising candidates in the pipeline including Foamix’s FMX-101 and Dermira’s DRM-101.
Polaris Market Research has provided the forecasts of the Global Dermatology Drugs Market from 2016-2022. The major segments which has been investigated in the global market from 2016-2022 are:
- Market Analysis by Dermatology Key Indications
- Market Analysis by Treatment Class/Marketed Drugs
- Market Analysis by Regions
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market/request-for-sample
The Marketed Therapies undertaken in forecast from 2016-2022 are:
- etanercept; Enbrel
- infliximab; Remicade
- adalimumab; Humira
- ustekinumab; Stelara
- secukinumab; Cosentyx
- ixekizumab; Taltz
- golimumab; Simponi
- brodalumab; Siliq
- guselkamab; Tremfya
- Topical Drugs
- Oral Antibiotics
The Major Indications in Dermatology Therapy area:
- Atopic Dermatitis
- Psoriasis
- Acne
- Rosacea
Leading Companies investigated in the Report are:
- Allergan Plc
- Valeant Pharmaceuticals
- Dermira Inc
- Aclaris Therapeutics, Inc
- AnaptysBio, Inc
- Revance Therapeutics
- Foamix Pharmaceuticals
- Novan, Inc
- Sienna Biopharmaceuticals
- Pfizer
- Sanofi
- Galderma
- Leo Pharma
- Roviant Sciences
- Otsuka Pharmaceuticals
To get Incredible Discounts on this Premium Report, Click At : https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: [email protected]
The Business Research Company published its Dermatology Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global dermatology drugs market.
The report covers the dermatology drugs market’s segments- acne, dermatitis, psoriasis, and others.The dermatology drugs market expected to reach a value of nearly $91.28 billion by 2022, significantly growing at a CAGR of 12.0% during the forecast period.Request Sample Pages on your Business E-mail AddressPharmaceutical companies are offering new drugs, referred to as immune modulators, for the treatment of skin diseases such as eczema.
Eczema is a chronic skin condition caused by the lack of skin proteins that results in inflammation and irritation in the skin.
These drugs are used to externally treat the skin without changing the immune system of the body.
In addition, unlike topical steroids, these new medications do not cause thinning of the skin and breaking of superficial blood vessels.Dermatology Drugs Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
